// App-Quantinova.ai

e20572 : EGFR T790M resistance mutation in NSCLC: Real-life data of patients treated with osimertinib.

Researchers

Presenter

  • Maximilian J. Hochmair

Principal Investigators

  • Sophia Holzer

  • Martin Filipits

  • Andrea Mohn-Staudner

  • Madeleine Arns

  • Peter Errhalt

  • Gudrun Absenger

  • Ursula Koller-Herzog

  • Ulrike Setinek

  • Ferdinand Haslbauer

  • Mark A. Korger

  • Kurt Patocka

  • Rainer Kolb

  • Otto Burghuber

Medical Centers

  • Department of Respiratory and Critical Care Medicine, Otto Wagner Hospital, Vienna, Austria

  • 2Institute of Cancer Research, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

  • Department of Respiratory and Critical Care Medicine, Otto Wagner Hospital, Vienna, Austria

  • Department of Pneumology, University Hospital Krems, Krems, Austria

  • Division of Oncology, Medical University of Graz, Graz, Austria

  • Department of Pneumology , Landeskrankenhaus Hochegg, Grimmenstein, Austria

  • Pathology Otto Wagner Spital, Vienna, AK, Austria

  • Hospital Vocklabruck/Department of Internal Medicine, Vocklabruck, Austria

  • Barmherzige Bruder Eisenstadt, Eisenstadt, Austria

  • Abteilung fur Atmungs und Lungenerkrankungen, Krankenhaus Hietzing, Vienna, Austria

  • Landeskrankenhaus Wels, Wels, Austria

Locations

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • Epidermal growth factor receptor

  • Threonine at amino acid position 790

Drug/Treatment

  • Tagrisso

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved